SCHEMBL6360940

SCHEMBL6360940

O=C(Cc1ccccc1)CN1CCN(c2ccccn2)CC1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
POLB P06746 3/20 0.58
ALDH1A1 P00352 8/20 0.57
MAPT P10636 3/20 0.57
HTR1A P08908 1/20 0.57
HTR7 P34969 1/20 0.57
KDM4E B2RXH2 4/20 0.56
GAA P10253 2/20 0.56
LMNA P02545 1/20 0.56
DRD2 P14416 2/20 0.56
DRD4 P21917 2/20 0.56
DRD3 P35462 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
TSHR P16473 1/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5174282 0.84 NPSR1 (0.71) THRBNPSR1POLBALDH1A1MAPT
Hydrochloric Acid SCHEMBL1373101 0.83 NPSR1 (0.69) THRBNPSR1POLBALDH1A1MAPT
SCHEMBL10403767 0.81 THRB (0.67) THRBNPSR1POLBALDH1A1MAPT
SCHEMBL9080030 0.81 HTR1A (0.61) THRBNPSR1POLBALDH1A1HTR1A
SCHEMBL23682791 0.81 KDM4E (0.81) NPSR1ALDH1A1HTR7KDM4ELMNA
SCHEMBL5174004 0.81 ALDH1A1 (0.63) THRBNPSR1POLBALDH1A1MAPT
SCHEMBL4006676 0.81 ALDH1A1 (0.77) THRBNPSR1POLBALDH1A1MAPT
SCHEMBL5544596 0.80 THRB (0.65) THRBNPSR1POLBALDH1A1MAPT
SCHEMBL4405017 0.80 THRB (0.65) THRBNPSR1POLBALDH1A1MAPT
SCHEMBL10772825 0.80 THRB (0.65) THRBNPSR1POLBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050176727-A1 Oximes and hydrazones that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2005-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176727-A1 Oximes and hydrazones that are useful in treating sexual dysfunction CYP19A1, SHBG, CYP17A1 THRB 3202/4885NPSR1 782/4885POLB 1708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.